Dr. Reddys Laboratories is currently trading at Rs. 5229.50, down by 23.85 points or 0.45% from its previous closing of Rs. 5253.35 on the BSE.
The scrip opened at Rs. 5279.00 and has touched a high and low of Rs. 5279.00 and Rs. 5220.00 respectively. So far 6731 shares were traded on the counter.
The BSE group ‘A’ stock of face value Rs. 5 has touched a 52 week high of Rs. 5514.65 on 21-Sep-2020 and a 52 week low of Rs. 3815.80 on 07-Jul-2020.
Last one week high and low of the scrip stood at Rs. 5351.00 and Rs. 5170.55 respectively. The current market cap of the company is Rs. 87064.61 crore.
The promoters holding in the company stood at 26.74%, while Institutions and Non-Institutions held 43.93% and 17.06% respectively.
Dr. Reddy’s Laboratories is recalling 2,980 bottles of Atorvastatin Calcium tablets in the US due to quality issues. Atorvastatin is indicated to lower cholesterol in the blood for adults and children over ten years of age.
The drug is also prescribed to lower the risk of heart attack and stroke in patients with cardiovascular diseases, diabetes, and other risk factors such as eye problems, kidney diseases, or high blood pressure.
Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.